Aqualung is an early-stage biotech company that develops immune-based therapeutic antibodies to treat acute and chronic lung inflammation conditions... Read more
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$22.3M

News

Dec 05, 2023
Accesswire
Press Release: Aqualung Therapeutics : First Patient Enrolled in the PUERTA Phase 2A ARDS Clinical Trial: Treatment with Aqualung Therapeutics ALT-100 mAb
Jul 18, 2023
Accesswire
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Receives FDA Clearance To Proceed With the P2A PUERTA Study in Moderate/Severe Acute Respiratory Distress Syndrome (ARDS) Patients
Jan 31, 2023
PR-Inside
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Concludes ALT-100 Antibody (mAb) Dosing in Its ...
Dec 05, 2022
PR-Inside
Press Release: Aqualung Therapeutics : Aqualung Therapeutics, an Immunotherapeutics Biotech Company, Receives ...
Sep 26, 2022
Accesswire
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Corp. Announces FDA Clearance of Investigational New Drug (IND) Application for ALT-100, a Novel mAb Therapy for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
Sep 21, 2022
Accesswire
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Corp. Awarded $4.8M Dollars From National Institute of Health (NIH) To Develop the ALT-100 Monoclonal Antibody for Pulmonary Arterial Hypertension and Inflammatory Bowel Disease
Sep 13, 2022
Accesswire
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Receives the AZ-Bio Fast Lane Award and Achieves Key FDA-Related Milestones
Jul 06, 2022
PR-Inside
Press Release: Aqualung Therapeutics : First in Human Subjects Enrolled in Aqualung Therapeutics Phase 1A ...
Jun 08, 2022
PR-Inside
Press Release: Aqualung Therapeutics : Aqualung Therapeutics Appoints Two New Board Directors; Will Attend ...
Apr 26, 2022
Accesswire
Press Release: Aqualung Therapeutics : LeaderMed Group Expands Pipeline with Aqualung License

Aqualung Therapeutics Competitors

1Breath Therapeutics
2Windtree
3Bellerophon Therapeutics
4Synairgen
5Verona Pharma
6Enterprise Therapeutics
7ReViral
8Medexus Pharma, Inc.
9OxyMaster
10Aerogen

Trending Companies